High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

Blood

Volumn 99, Issue 9, 2002, Pages 3158-3162

  Gopal, Ajay K ^a,b,c   Rajendran, Joseph G ^a,b   Petersdorf, Stephen H ^a,b   Maloney, David G ^a,b   Eary, Janet F ^a,b   Wood, Brent L ^a,b   Gooley, Theodore A ^a,b   Bush, Sharon A ^a,b   Durack, Lawrence D ^a,b   Martin, Paul J ^a,b   Matthews, Dana C ^a,b   Appelbaum, Frederick R ^a,b   Bernstein, Irwin D ^a,b   Press, Oliver W ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IODINE 131; METHYLPREDNISOLONE; POTASSIUM IODIDE; PREDNISONE; RITUXIMAB; TOSITUMOMAB; VINCRISTINE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; DRUG UPTAKE; FEMALE; HUMAN; MALE; MANTLE CELL LYMPHOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0036566227     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.9.3158     Document Type: Article

References (26)

1. Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: Results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group
2. Mantle-cell lymphoma: A population-based clinical study
3. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project
4. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study
5. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: No evidence for long-term remission
6. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma
7. Autologous hematopoietic stem cell transplantation for mantle cell lymphoma
8. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma
9. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma
10. High dose therapy with allogeneic or autologous stem cell transplantation for relapsed mantle cell lymphoma: The Seattle experience
11. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone
12. Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy
13. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University
14. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support
15. Phase II trial of 1311-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas
16. A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas
17. Imaging and treatment of B-cell lymphoma
18. Regimen-related toxicity in patients undergoing bone marrow transplantation
19. Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older
20. Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation
21. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma
22. International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report of the jury
23. Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma
24. Role of radiation therapy in localized non-Hodgkin's lymphoma
25. Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue
26. Levels of expression of CD19 and CD20 in chronic B cell leukaemias